Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.

Romano S, Ferraldeschi M, Bagnato F, Mechelli R, Morena E, Caldano M, Buscarinu MC, Fornasiero A, Frontoni M, Nociti V, Mirabella M, Mayer F, Bertolotto A, Pozzilli C, Vanacore N, Salvetti M, Ristori G.

Front Neurol. 2019 Jul 16;10:695. doi: 10.3389/fneur.2019.00695. eCollection 2019.

2.

Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.

Iannetta M, Zingaropoli MA, Latronico T, Pati I, Pontecorvo S, Prezioso C, Pietropaolo V, Cortese A, Frontoni M, D'Agostino C, Francia A, Vullo V, Mastroianni CM, Liuzzi GM, Ciardi MR.

Sci Rep. 2019 Jan 22;9(1):311. doi: 10.1038/s41598-018-36535-5.

3.

Photophobia in multiple sclerosis.

Cortese A, Conte A, Ferrazzano G, Sgarlata E, Millefiorini E, Frontoni M, Berardelli A.

Mult Scler Relat Disord. 2018 Nov;26:55-57. doi: 10.1016/j.msard.2018.09.005. Epub 2018 Sep 8.

PMID:
30223230
4.

JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.

Zingaropoli MA, Iannetta M, Pontecorvo S, Anzivino E, Prezioso C, Rodio DM, Morreale M, D'Abramo A, Oliva A, Lichtner M, Cortese A, Frontoni M, Pietropaolo V, Francia A, Mastroianni CM, Vullo V, Ciardi MR.

Biomed Res Int. 2018 Feb 27;2018:5297980. doi: 10.1155/2018/5297980. eCollection 2018.

5.

A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.

Truini A, Prosperini L, Calistri V, Fiorelli M, Pozzilli C, Millefiorini E, Frontoni M, Cortese A, Caramia F, Cruccu G.

Neurology. 2016 May 31;86(22):2094-9. doi: 10.1212/WNL.0000000000002720. Epub 2016 May 4.

PMID:
27164695
6.

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.

Kuhle J, Hardmeier M, Disanto G, Gugleta K, Ecsedi M, Lienert C, Amato MP, Baum K, Buttmann M, Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M, D'Hooghe M, Hutchinson M, De Keyser J, Kieseier BC, Kümpfel T, Rio J, Polman C, Roullet E, Stolz C, Vass K, Wandinger KP, Kappos L; European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis.

Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440. Epub 2015 Sep 11.

PMID:
26362898
7.

Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study.

Marchione P, Morreale M, Giacomini P, Izzo C, Pontecorvo S, Altieri M, Bernardi S, Frontoni M, Francia A.

PLoS One. 2014 Oct 31;9(10):e111486. doi: 10.1371/journal.pone.0111486. eCollection 2014.

8.

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M.

Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4.

9.

Parkinson's disease related pain: a review of recent findings.

Truini A, Frontoni M, Cruccu G.

J Neurol. 2013 Jan;260(1):330-4. doi: 10.1007/s00415-012-6754-5. Epub 2012 Nov 23. Review.

10.

Fatigue in Parkinson's disease: motor or non-motor symptom?

Fabbrini G, Latorre A, Suppa A, Bloise M, Frontoni M, Berardelli A.

Parkinsonism Relat Disord. 2013 Feb;19(2):148-52. doi: 10.1016/j.parkreldis.2012.10.009. Epub 2012 Oct 26. Review.

PMID:
23107555
11.

Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study.

Onesti E, Bagnato F, Tomassini V, Volante G, Denaro F, Frontoni M, Millefiorini E, Pozzilli C, Fieschi C.

Neurol Sci. 2003 Dec;24(5):340-5.

PMID:
14716530
12.

Can the Expanded Disability Status Scale be assessed by telephone?

Lechner-Scott J, Kappos L, Hofman M, Polman CH, Ronner H, Montalban X, Tintore M, Frontoni M, Buttinelli C, Amato MP, Bartolozzi ML, Versavel M, Dahlke F, Kapp JF, Gibberd R.

Mult Scler. 2003 Mar;9(2):154-9.

PMID:
12708811
13.

Malignant gastric carcinoid and paraneoplastic cerebellar degeneration.

Balducci G, Frontoni M, Bocchetti T, Angelini D, Di Giacomo G, Ziparo V.

Eur J Surg. 1999 Dec;165(12):1193-6. No abstract available.

PMID:
10636557
14.

MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns.

Pozzilli C, Falaschi P, Mainero C, Martocchia A, D'Urso R, Proietti A, Frontoni M, Bastianello S, Filippi M.

Neurology. 1999 Aug 11;53(3):622-4.

PMID:
10449131
15.

Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1a.

Paolillo A, Bastianello S, Frontoni M, Gasperini C, Giugni E, Ciccarelli O, Luccichenti G, Cannoni S, Pozzilli C.

J Neurol. 1999 Jun;246(6):443-8.

PMID:
10431768
16.

Cardiac autonomic dysfunction in patients with Alzheimer disease: possible pathogenetic mechanisms.

Giubilei F, Strano S, Imbimbo BP, Tisei P, Calcagnini G, Lino S, Frontoni M, Santini M, Fieschi C.

Alzheimer Dis Assoc Disord. 1998 Dec;12(4):356-61.

PMID:
9876965
17.

Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosis.

Koudriavtseva T, Pozzilli C, Fiorelli M, Gasperini C, Bagnato F, Galgani S, Frontoni M, Ciccarelli O, Bastianello S.

Mult Scler. 1998 Oct;4(5):403-7.

PMID:
9839299
18.

No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis.

Colosimo C, Pozzilli C, Frontoni M, Farina D, Koudriavtseva T, Gasperini C, Salvetti M, Valesini G.

Acta Neurol Scand. 1997 Dec;96(6):372-4.

PMID:
9449474
19.

MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis.

Giugni E, Pozzilli C, Bastianello S, Gasperini C, Paolillo A, Koudriavtseva T, Frontoni M, Farina D, Bozzao L.

Mult Scler. 1997 Aug;3(4):221-5.

PMID:
9372503
20.

Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis.

Frontoni M, Fiorini M, Strano S, Cerutti S, Giubilei F, Urani C, Bastianello S, Pozzilli C.

Acta Neurol Scand. 1996 Apr;93(4):241-5.

PMID:
8739432
21.

Cardiac autonomic dysfunction in relapsing-remitting multiple sclerosis during a stable phase.

Giubilei F, Vitale A, Urani C, Frontoni M, Fiorini M, Millefiorini E, Fiorelli M, Santini M, Strano S.

Eur Neurol. 1996;36(4):211-4.

PMID:
8814423
22.

A prospective study of cerebral ischemia in the young. Analysis of pathogenic determinants. The National Research Council Study Group.

Carolei A, Marini C, Ferranti E, Frontoni M, Prencipe M, Fieschi C.

Stroke. 1993 Mar;24(3):362-7.

PMID:
8446970
23.

Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients?

Toni D, Sacchetti ML, Argentino C, Gentile M, Cavalletti C, Frontoni M, Fieschi C.

J Neurol. 1992 Aug;239(7):382-6.

PMID:
1403020
24.

Evaluation of medical therapies of acute ischemic stroke.

Fieschi C, Carolei A, Frontoni M, Argentino C, Toni D, Sacchetti ML, Fiorini M.

J Stroke Cerebrovasc Dis. 1992;2(1):47-50. doi: 10.1016/S1052-3057(10)80036-9. Epub 2010 Jun 11. No abstract available.

PMID:
26486436
25.

Reversed laterality of cerebral functions in a non-right-hander: neuropsychological and spect findings in a case of 'atypical' dominance.

Padovani A, Pantano P, Frontoni M, Iacoboni M, Di Piero V, Lenzi GL.

Neuropsychologia. 1992 Jan;30(1):81-9.

PMID:
1738472
26.

Effect of stress on cardiovascular regulation in neurological diseases with dysautonomia.

Frontoni M, Giubilei F, Millefiorini E, Antonini G, Fiorini M, Vichi R, Urani C, Strano S, Fieschi C.

Acta Neurol (Napoli). 1991 Aug;13(4):374-9.

PMID:
1781313
27.

Controlled clinical trials in stroke.

Fieschi C, Frontoni M, Argentino C, Orzi F, Toni D, Millefiorini E, Carolei A, Cavalletti C.

Arzneimittelforschung. 1991 Mar;41(3A):344-7. Review.

PMID:
1859506
28.

Update on calcium antagonists in cerebrovascular diseases.

Toni D, Frontoni M, Argentino C, Sacchetti ML, De Michele M, Fieschi C.

J Cardiovasc Pharmacol. 1991;18 Suppl 8:S10-4. Review.

PMID:
1726729
29.

A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor.

Casacchia M, Carolei A, Barba C, Frontoni M, Rossi A, Meco G, Zylberman MR.

Pharmacopsychiatry. 1984 Jul;17(4):122-5.

PMID:
6382361
30.

[Tricyclics, MAOI and electroshock therapy in the treatment of depressive syndromes].

Carolei A, Frontoni M.

Clin Ter. 1981 Jul 15;98(1):75-86. Review. Italian. No abstract available.

PMID:
7018824
31.

[Tremor: clinical aspects and possibility of therapeutic intervention].

Carolei A, Frontoni M.

Clin Ter. 1981 Apr 15;97(1):93-6. Italian. No abstract available.

PMID:
6116555

Supplemental Content

Loading ...
Support Center